Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PepGen Inc. Director's Dealing 2025

Sep 30, 2025

33898_dirs_2025-09-30_9a5e1834-79e7-4f36-9ac0-838b3f6e4038.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PepGen Inc. (PEPG)
CIK: 0001835597
Period of Report: 2025-09-26

Reporting Person: RA CAPITAL MANAGEMENT, L.P. (N/A)
Reporting Person: RA Capital Healthcare Fund LP (Director, 10% Owner)
Reporting Person: RA Capital Nexus Fund II, L.P. (Director)
Reporting Person: Kolchinsky Peter (Director, 10% Owner)
Reporting Person: Shah Rajeev M. (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-09-26 Common Stock P 9375000 $3.20 Acquired 18554273 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1302600 Indirect
Common Stock 207672 Indirect

Footnotes

F1: These securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund").

F2: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"), and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.

F3: These securities are held directly by the Nexus Fund II.

F4: These securities are held directly by the Account.